Cancer treatment without insurance can cost anywhere from $10,000 to well over $200,000 depending on the type of cancer, the stage at diagnosis, and which treatments you need. There is no single price tag because cancer care involves multiple overlapping expenses: surgery, chemotherapy, radiation, imaging, lab work, supportive medications, and follow-up visits, each billed separately and varying widely by location and provider.
Chemotherapy Costs
Chemotherapy is one of the most common cancer treatments, and it’s also one of the most variable in price. A six-month course of chemotherapy averages around $27,000, but that figure can swing dramatically depending on the specific drugs used, how many cycles you need, and whether you receive treatment at a hospital outpatient center or a freestanding clinic. Some newer chemotherapy regimens cost significantly more.
These numbers cover the drugs themselves. They don’t include the infusion center fees, blood work before each session, or the hours of nursing time billed alongside every visit. When you add those facility and administration charges, the real out-of-pocket cost of chemotherapy climbs well beyond the drug price alone.
Immunotherapy and Targeted Therapy
Newer cancer drugs, particularly immunotherapy and targeted therapy, are among the most expensive treatments in medicine. A single vial of pembrolizumab, one of the most widely prescribed immunotherapy drugs, costs $4,400. A typical treatment cycle combining immunotherapy with chemotherapy runs roughly $9,000 every three weeks. Over a year of treatment, that adds up to more than $150,000 in drug costs alone.
These prices reflect the list cost before any negotiation or discount. National spending on cancer drugs hit $99 billion in 2023 and is projected to reach $180 billion by 2028, driven largely by the rapid adoption of immunotherapy and targeted treatments. For uninsured patients, this category of drugs represents the single largest financial risk in cancer care.
Radiation Therapy Costs
A full course of radiation therapy ranges from $4,500 to $50,000. The wide spread depends on the type of radiation, how many sessions you need, and where you receive treatment. Standard external beam radiation delivered over several weeks falls toward the middle of that range. More advanced techniques, such as stereotactic body radiation or proton therapy, push costs toward the upper end.
Most radiation plans involve daily sessions five days a week for three to seven weeks. Each session is billed individually, and you’ll also see separate charges for the initial treatment planning, imaging to map the tumor, and the physicist’s work designing your radiation fields.
Surgery Expenses
Surgical costs vary enormously by procedure. A relatively straightforward tumor removal might cost $10,000 to $30,000, while complex operations like a lung resection, radical hysterectomy, or multi-organ procedure can run $50,000 to $100,000 or more. These figures include the surgeon’s fee, anesthesia, operating room time, and a hospital stay if needed. If you require an intensive care unit bed after surgery, each day there can add thousands to the bill.
Pathology charges are billed separately. Every tissue sample sent to a lab for analysis during or after surgery generates its own line item, and those costs add up quickly when surgeons need to check multiple margins or lymph nodes.
Diagnostic Imaging and Lab Work
Before treatment begins and at regular intervals throughout, you’ll need imaging scans to track the cancer. A PET scan, which is the standard for staging many cancers and monitoring treatment response, costs around $2,200 or more without insurance. CT scans typically range from $500 to $3,000 depending on the body region and whether contrast dye is used. MRIs fall in a similar range.
Most treatment plans require imaging every two to three months during active treatment, then every three to six months for several years of surveillance afterward. Blood work, biopsies, and genetic testing of tumor samples add further costs. Genomic profiling tests that help oncologists choose the right targeted therapy can cost $3,000 to $7,000 per test.
Supportive Medications Add Up Fast
One of the most overlooked expenses in cancer treatment is the cost of drugs that manage side effects. Anti-nausea medications alone can cost anywhere from under $10 to over $1,400 per chemotherapy cycle, depending on which drugs your oncologist prescribes and whether generic versions are available.
A standard four-drug anti-nausea regimen for aggressive chemotherapy ranges from $181 to $1,430 per cycle at cash prices with coupons. The difference comes down almost entirely to brand-name versus generic choices. Generic ondansetron tablets cost as little as $3, while the brand-name dissolving film version of the same drug costs $516 for the same quantity. If you need medications for breakthrough nausea between treatments, those add another layer of expense, from $2 to $3 per week for common generics up to $1,440 per week for certain brand-name formulations.
Beyond nausea drugs, you may need medications to boost white blood cell counts, manage pain, treat infections, or address other chemotherapy side effects. Each of these is billed separately and can cost hundreds to thousands of dollars per month.
Total Cost Estimates by Cancer Type
Putting all these pieces together, here’s a rough sense of what total treatment costs look like for common scenarios without insurance:
- Early-stage breast cancer (surgery, radiation, short chemotherapy course): $30,000 to $100,000
- Colon cancer (surgery plus six months of chemotherapy): $40,000 to $120,000
- Lung cancer with immunotherapy (imaging, chemotherapy, immunotherapy for a year or more): $150,000 to $300,000+
- Lymphoma (six months of chemotherapy, imaging, lab work): $25,000 to $80,000
These ranges are broad because no two cancer cases follow the same path. Complications, additional surgeries, extended treatment courses, or hospital admissions for side effects can push totals far beyond initial estimates.
Ways to Reduce Costs Without Insurance
If you’re facing cancer treatment without insurance, several programs exist specifically to bring costs down.
Hospital Financial Assistance
Nonprofit hospitals are required to offer financial assistance programs, sometimes called charity care. Eligibility is based on your income relative to the federal poverty level. As a general example, many hospitals provide full financial assistance (a $0 bill) for patients earning 200% or less of the federal poverty level, which is roughly $62,400 for a family of four in 2025. Patients earning between 200% and 300% of the poverty level often qualify for discounted rates, and those up to 500% may have their bills capped at a percentage of what Medicare would pay for the same services. You have to apply, and the hospital won’t automatically offer this. Ask the billing department for a financial assistance application before treatment starts.
Drug Manufacturer Assistance Programs
Most major pharmaceutical companies run patient assistance programs that provide cancer drugs at no cost or reduced cost to qualifying patients. These programs typically require proof of income, a prescription from your oncologist, and documentation that you lack adequate insurance coverage. The Pharmaceutical Research and Manufacturers of America maintains the Medicine Assistance Tool, a searchable database of available programs. Your oncology team’s social worker or financial counselor can help you navigate the application process.
Negotiating and Shopping Around
Cash-paying patients can often negotiate significantly lower rates than the sticker price on a hospital bill. Many facilities offer prompt-pay discounts of 20% to 40% for patients who pay upfront or set up a payment plan. For imaging and lab work, prices vary dramatically between providers in the same city, so comparing costs at freestanding imaging centers versus hospital-based facilities can save thousands of dollars over the course of treatment.
The Medicare Drug Price Changes Ahead
Starting in January 2026, negotiated prices for certain cancer drugs covered under Medicare Part D will take effect, with Part B drug negotiations following in 2028. While these changes primarily affect Medicare beneficiaries, they could influence broader drug pricing. However, some analysts expect that manufacturers may raise launch prices on new cancer drugs to offset the revenue impact, meaning the cost picture for uninsured patients paying cash could get worse before it gets better.